Katherine E. Harris - Publications

Affiliations: 
 

14 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Buelow B, Avanzino B, Balasubramani A, Boudreau A, Davison L, Ganesan P, Harris K, Hartstein S, Malik-Chaudhry H, Pham D, Prabhakar K, Rangaswamy U, Saiganesh S, Schellenberger U, Ugamraj H, et al. A CD3 x FRα T-cell engaging bispecific antibody for efficient killing of ovarian cancer cells with minimal cytokine release. Journal of Clinical Oncology. 38: e18050-e18050. DOI: 10.1200/Jco.2020.38.15_Suppl.E18050  0.391
2020 Buelow B, Dang K, Dalvi P, Li Y, Cheung A, Rancan C, Sankaran P, Pham D, Harris K, Davison L, Balasubramani A, Clarke S, Starzinski A, Fong L, Iyer S. Effect of modulation of CD3 binding in a PSMAxCD3 T-cell engaging bispecific antibody on maintenance of efficient tumor cell kill and cytokine release. Journal of Clinical Oncology. 38: e17583-e17583. DOI: 10.1200/jco.2020.38.15_suppl.e17583  0.394
2019 Trinklein ND, Pham D, Schellenberger U, Buelow B, Boudreau A, Choudhry P, Clarke SC, Dang K, Harris KE, Iyer S, Jorgensen B, Pratap PP, Rangaswamy US, Ugamraj HS, Vafa O, et al. Efficient tumor killing and minimal cytokine release with novel T-cell agonist bispecific antibodies. Mabs. PMID 30698484 DOI: 10.1080/19420862.2019.1574521  0.381
2019 Clarke S, Dang K, Li Y, Sankaran P, Pham D, Balasubramani A, Davison L, Harris K, Jorgensen B, Schellenberger U, Trinklein N, Ugamraj H, Buelow R, Van Schooten W, Force Aldred S, et al. A novel CD3xPSMA bispecific antibody for efficient T cell mediated killing of prostate tumor cells with minimal cytokine release. Journal of Clinical Oncology. 37: 324-324. DOI: 10.1200/Jco.2019.37.7_Suppl.324  0.397
2019 Buelow B, Clarke S, Dang K, Li J, Rancan C, Li Y, Sankaran P, Pham D, Balasubramani A, Davison L, Harris K, Jorgensen B, Schellenberger U, Trinklein N, Ugamraj H, et al. Evaluation of monovalent versus biparatopic CD3xPSMA bispecific antibodies for t-cell mediated killing of prostate tumor cells with minimal cytokine release. Journal of Clinical Oncology. 37: e16519-e16519. DOI: 10.1200/Jco.2019.37.15_Suppl.E16519  0.393
2019 Lorentsen K, Sankaran P, Trinklein ND, Pham D, Schellenberger U, Buelow B, Boudreau A, Choudhry P, Clarke SC, Dang K, Harris KE, Iyer S, Jorgensen B, Pratap P, Rangaswamy US, et al. Abstract 1554: Uncoupling tumor-cell cytotoxicity from cytokine release with novel T-cell engaging bispecific antibodies Cancer Research. 79: 1554-1554. DOI: 10.1158/1538-7445.Am2019-1554  0.391
2018 Buelow B, Choudhry P, Clarke S, Dang K, Davison L, Force Aldred S, Harris K, Pham D, Pratap P, Rangaswamy U, Schellenberger U, Shah N, Trinklein N, Ugamraj H, Wiita A, et al. Development of a fully human t-cell engaging bispecific antibody for the treatment of multiple myeloma. Journal of Clinical Oncology. 36: 60-60. DOI: 10.1200/Jco.2018.36.5_Suppl.60  0.384
2018 Force Aldred S, Boudreau A, Buelow B, Clarke S, Dang K, Davison L, Harris K, Iyer S, Jorgensen B, Ogana H, Pham D, Pratap P, Rangaswamy U, Schellenberger U, Trinklein N, et al. Multispecific antibodies targeting CD38 show potent tumor-specific cytotoxicity. Journal of Clinical Oncology. 36: 57-57. DOI: 10.1200/Jco.2018.36.5_Suppl.57  0.333
2018 Rangaswamy U, Boudreau A, Buelow B, Clarke S, Dang K, Davison L, Force Aldred S, Harris K, Iyer S, Jorgensen B, Ogana H, Pham D, Pratap P, Trinklein N, Schellenberger U, et al. A novel T-cell bispecific antibody platform for efficient T-cell mediated killing of tumor cells with minimal cytokine release. Journal of Clinical Oncology. 36: 209-209. DOI: 10.1200/Jco.2018.36.5_Suppl.209  0.384
2018 Buelow B, Choudry P, Clarke S, Dang K, Davison L, Force Aldred S, Harris K, Pratap P, Pham D, Rangaswamy U, Schellenberger U, Shah N, Trinklein N, Ugamraj H, Wiita A, et al. Pre-clinical development of TNB-383B, a fully human T-cell engaging bispecific antibody targeting BCMA for the treatment of multiple myeloma. Journal of Clinical Oncology. 36: 8034-8034. DOI: 10.1200/Jco.2018.36.15_Suppl.8034  0.351
2018 Malik H, Buelow B, Avanzino B, Balasubramani A, Boudreau A, Clarke S, Dang K, Davison L, Force Aldred S, Harris K, Jorgensen B, Li Y, Medlari H, Narayan K, Ogana H, et al. A Novel Fully Human Bispecific CD19 x CD3 Antibody That Kills Lymphoma Cells with Minimal Cytokine Secretion Blood. 132: 1671-1671. DOI: 10.1182/Blood-2018-99-118913  0.371
2017 Buelow B, Pham D, Choudhry P, Dang K, Pratap P, Clarke S, Harris K, Jorgensen B, Aldred SF, Schellenberger U, Shah N, Trinklein N, Wiita AP, Iyer S, Schooten WV. T Cell Engagement without Cytokine Storm: A Novel Bcma x CD3 Antibody Killing Myeloma Cells with Minimal Cytokine Secretion Blood. 130: 501-501. DOI: 10.1182/Blood.V130.Suppl_1.501.501  0.357
2007 Harris KE, Beckendorf SK. Different Wnt signals act through the Frizzled and RYK receptors during Drosophila salivary gland migration. Development (Cambridge, England). 134: 2017-25. PMID 17507403 DOI: 10.1242/Dev.001164  0.574
2007 Harris KE, Schnittke N, Beckendorf SK. Two ligands signal through the Drosophila PDGF/VEGF receptor to ensure proper salivary gland positioning. Mechanisms of Development. 124: 441-8. PMID 17462868 DOI: 10.1016/J.Mod.2007.03.003  0.577
Show low-probability matches.